Update Course Rewind: MMP-7 & Biliary Atresia Diagnosis 2024

In this Update Course Rewind session, Dr. Greg Tiao, Surgical Director of the Liver Transplantation Program at Cincinnati Children’s, discusses the critical role of MMP-7 as a biomarker in the early diagnosis of biliary atresia. With data showing that every 10-day delay in treatment worsens outcomes by 20%, early detection is essential for improving native liver survival.Key Highlights:Importance of Early Diagnosis: Performing a Kasai procedure before 45 days significantly improves patient outcomes.MMP-7 as a Biomarker: Validated in international studies, MMP-7 is proving to be a powerful diagnostic tool.Challenges in Diagnosis: Distinguishing BA from other neonatal cholestasis conditions remains complex.Global Impact: Lessons from high-incidence regions like China are helping shape best practices in North America.With the integration of MMP-7 testing, pediatric surgery is moving towards earlier diagnosis and intervention, improving the chances of avoiding liver transplant in affected infants. Don’t forget to like, comment, and subscribe for more updates!